Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Thai Chung who wrote (3540)	7/18/2000 9:32:39 AM
From: John R Resseger	Read Replies (2) \| Respond to of 3725

)--July 18, 2000--Imatron Inc. (Nasdaq:IMAT - news) announced today that it has sold an Electron Beam Tomography (EBT) scanner to BodyScan Imaging LLC in Kansas City, Missouri. This system sale will be reflected in the Company's third quarter financial results. BodyScan Imaging LLC will provide imaging services to detect coronary artery disease, carotid artery disease, lung cancer and osteoporosis. In addition, BodyScan Imaging will offer electron beam angiography (EBA). BodyScan Imaging will market its preventive health services to both physicians and the general public. The center will be located in Kansas City, Missouri and will serve both Kansas City, Missouri and Kansas and the entire Western Missouri area. The facility is expected to be operational in September 2000. In addition to this center, a number of other BodyScan Imaging centers are in the planning and development stage. Anthony Sciuto, President of BodyScan Imaging LLC, stated, ``We are looking forward to opening our first diagnostic center in Kansas City, Missouri. We are forging important medical alliances both in Kansas City, Missouri and Kansas and are expanding this effort to build a strong support base for our success. The expansion of BodyScan Imaging demonstrates our firm belief in and commitment to Imatron's EBT technology as the 'gold standard' for cardiac diagnostics in preventive medicine.'' Dr. Julie Keck, Ph.D., Director of Medical Services, stated, ``We are pleased to bring Imatron's EBT scanner to Kansas City and offer the public and the medical community leading-edge technology to assist physicians in detecting coronary artery disease and lung cancer, among other preventable and treatable diseases. After extensive consideration of the potential life-saving benefits of this state-of-the-art technology, and the significant business opportunity presented by owning and operating an EBT scanner, we are looking forward to making this technology accessible to the Western Missouri area.'' For additional information about BodyScan Imaging, visit the company's website at www.bodyscanimaging.com. S. Lewis Meyer, Imatron's CEO, commented, ``In previous announcements of EBT scanner sales, we have highlighted the significance of bringing local medical expertise and private capital together to create a strong regional business model. BodyScan Imaging LLC is an excellent example of precisely this marriage between financial resources and healthcare experience in action. We are now seeing this type of strategy replicated in a wide variety of situations across the country. It is very encouraging to see Imatron's second fiscal quarter sales momentum continuing into the third quarter. We are solidly on schedule to meet or exceed our revenue objectives and to report increasingly profitable quarterly operations throughout the 2000 fiscal year.'' For additional information about Imatron, visit the Company's web site at www.imatron.com.